Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9925100.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Persistent minor hemoptysis resulted from extensive granulation tissue on the main carina and adjacent bronchi due to frequent spraying of metered-dose inhaler (MDI)-generated aerosol medications directly into a permanent tracheostomy. Salbutamol, containing oleic acid, was considered the most likely cause. After an AeroChamber equipped with an infant mask was interposed between the MDI and the tracheal stoma, hemoptysis and the pathologic changes gradually resolved.
Medical subject headings
- Albuterol
- Hemoptysis
- Lung Diseases, Obstructive
- Nebulizers and Vaporizers
- Oleic Acid
- Postoperative Complications
- Tracheostomy